Profile
| Metric | Value |
|---|---|
| Full Name | Sorrento Therapeutics, Inc. |
| Ticker | NASDAQ: SRNE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sorrentotherapeutics.com |
| Employees | 949 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.00 | |
| Price, 1D Change | 0.00% | |
| $2M | ||
| - | ||
| - | ||
| -1.24 | ||
| $63M | ||
| Revenue, 1Y Change | +18.78% | |
| -$1.37 | ||
| EPS, 1Y Change | +5.99% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | QBYT | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.37 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $62.84M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $0.00 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.05 | N/A | - | |
| - | N/A | - | |
| - | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $65.45M | N/A | - | |
| - | N/A | - | |
| $210.65M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.00 | |
| $0.00 | ||
| SMA 200 vs Price | -2.86% | |
| $0.00 | ||
| SMA 50 vs Price | +20.00% | |
| -1.24 | ||
| $0.00 | ||
| 50.00 | ||
| 254.37% | ||
| 2,373.60% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $62.84M | ||
| -$1.37 | ||
| $25.06M | ||
| 39.88% | ||
| -$378.50M | ||
| -602.33% | ||
| -$577.76M | ||
| -919.42% | ||
| -$361.03M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -7.23 | ||
| 0.29 | ||
| 0.26 | ||
| - | ||
| 3 | ||
| -9.30 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 0.03 | ||
| -0.01 | ||
| -0.38 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$18.61M | ||
| $49.98M | ||
| $514.49M | ||
| $96.37M | ||
| $536.16M | ||
| $327.92M | ||
| $134.50M | ||
| $30.17M | ||
| $47.52M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $635.68M | ||
| $403.56M | ||
| $37.78M | ||
| $182.34M | ||
| $17.48M | ||
| $0.00 | ||
| -$2.42M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$293.86M | ||
| -$28.52M | ||
| $311.72M | ||
| $13.66M | ||
| -$307.51M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Cantor Fitzgerald | ||
| HC Wainwright & Co. | ||
| HC Wainwright & Co. | ||
| Alliance Global Partners | ||
| HC Wainwright & Co. | ||
| Dawson James | ||
| HC Wainwright & Co. | ||
| H.C. Wainwright | ||
| JMP Securities | ||
| B. Riley Securities | → |
Analyst sentiment
Institutional ownership
Screeners with SRNE
FAQ
What is the ticker symbol for Sorrento Therapeutics, Inc.?
The ticker symbol for Sorrento Therapeutics, Inc. is NASDAQ:SRNE
Does Sorrento Therapeutics, Inc. pay dividends?
No, Sorrento Therapeutics, Inc. does not pay dividends
What sector is Sorrento Therapeutics, Inc. in?
Sorrento Therapeutics, Inc. is in the Healthcare sector
What industry is Sorrento Therapeutics, Inc. in?
Sorrento Therapeutics, Inc. is in the Biotechnology industry
What country is Sorrento Therapeutics, Inc. based in?
Sorrento Therapeutics, Inc. is headquartered in United States
When did Sorrento Therapeutics, Inc. go public?
Sorrento Therapeutics, Inc. initial public offering (IPO) was on January 19, 2007
Is Sorrento Therapeutics, Inc. in the S&P 500?
No, Sorrento Therapeutics, Inc. is not included in the S&P 500 index
Is Sorrento Therapeutics, Inc. in the NASDAQ 100?
No, Sorrento Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Sorrento Therapeutics, Inc. in the Dow Jones?
No, Sorrento Therapeutics, Inc. is not included in the Dow Jones index
When was Sorrento Therapeutics, Inc. last earnings report?
Sorrento Therapeutics, Inc.'s most recent earnings report was on November 22, 2023
When does Sorrento Therapeutics, Inc. report earnings?
The date for Sorrento Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- SRNE Official Website www.sorrentotherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/850261/000095017023041995/0000950170-23-041995-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/850261/000095017023008238/0000950170-23-008238-index.htm
- SRNE Profile on Yahoo Finance finance.yahoo.com/quote/SRNE
- SRNE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/srne